A study tied modest frailty gains in a prehab program to lower waitlist death risk in liver transplant candidates. Here is what caregivers can ask the care team. Fake Curses Fouch and Twizpipe Got ...

Women on CagriSema lost 25% of their body weight in a post hoc trial analysis, while 79.6% of users had digestive side effects. The drug is not approved. Ice Water, Math Quizzes, and Shocks: The 1948 ...

It’s been months since you recovered from but you’re still misplacing your keys or losing your train of thought mid-sentence. If this sounds familiar, you may be experiencing post-COVID brain fog.

Most people who get COVID recover within a few weeks. But for some, symptoms persist for months – a condition now known as long COVID. While it’s often associated with fatigue, breathlessness and ...

More than 6 years after the COVID-19 pandemic began, its effects have continued. In March 2024, roughly 17 million adults (7% of all U.S. adults) reported ever having symptoms consistent with long ...

A low-cost antidepressant may offer new hope for people struggling with long COVID fatigue. In a randomized clinical trial involving 399 adults, fluvoxamine significantly reduced fatigue and improved ...

More than three years after the global COVID-19 health emergency ended, the virus continues to cause hospitalisations and ...

Results from a clinical trial and published today in the journal Lancet Infectious Diseases show that the antiviral drug Paxlovid, commonly prescribed to treat acute COVID-19, does not affect long ...